168 related articles for article (PubMed ID: 32646809)
1. Cost-effectiveness Analysis of Non-risk-adapted Active Surveillance for Postorchiectomy Management of Clinical Stage I Seminoma.
Huang MM; Su ZT; Cheaib JG; Biles MJ; Allaf ME; Patel HD; Pierorazio PM
Eur Urol Focus; 2021 Nov; 7(6):1409-1417. PubMed ID: 32646809
[TBL] [Abstract][Full Text] [Related]
2. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
3. Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.
Pierorazio PM; Albers P; Black PC; Tandstad T; Heidenreich A; Nicolai N; Nichols C
Eur Urol; 2018 Jun; 73(6):899-907. PubMed ID: 29338978
[TBL] [Abstract][Full Text] [Related]
4. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness Analysis of
Su ZT; Patel HD; Huang MM; Meyer AR; Pavlovich CP; Pierorazio PM; Javadi MS; Allaf ME; Rowe SP; Gorin MA
Eur Urol Focus; 2021 Jul; 7(4):827-834. PubMed ID: 32115400
[TBL] [Abstract][Full Text] [Related]
6. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
Leung E; Warde P; Jewett M; Panzarella T; O'Malley M; Sweet J; Moore M; Sturgeon J; Gospodarowicz M; Chung P
BJU Int; 2013 Dec; 112(8):1088-95. PubMed ID: 23937685
[TBL] [Abstract][Full Text] [Related]
7. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
8. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
9. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
11. Surveillance in stage I seminoma patients: a long-term assessment.
Cummins S; Yau T; Huddart R; Dearnaley D; Horwich A
Eur Urol; 2010 Apr; 57(4):673-8. PubMed ID: 19545941
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma.
Sharda NN; Kinsella TJ; Ritter MA
J Clin Oncol; 1996 Nov; 14(11):2933-9. PubMed ID: 8918490
[TBL] [Abstract][Full Text] [Related]
13. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
[TBL] [Abstract][Full Text] [Related]
14. Barriers to the implementation of surveillance for stage I testicular seminoma.
Arvold ND; Catalano PJ; Sweeney CJ; Hoffman KE; Nguyen PL; Balboni TA; Fosså SD; Travis LB; Beard CJ
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):383-9. PubMed ID: 22349043
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options following orchiectomy for stage I seminoma.
Lawrentschuk N; Fleshner NE
Oncology (Williston Park); 2009 Aug; 23(9):749-53. PubMed ID: 19777758
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy.
Mistretta FA; Mazzone E; Palumbo C; Knipper S; Tian Z; Nazzani S; Lattouf JB; Musi G; Perrotte P; Montanari E; Shariat SF; Montorsi F; Saad F; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2019 Aug; 17(4):e793-e801. PubMed ID: 31182339
[TBL] [Abstract][Full Text] [Related]
17. Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.
Tyrrell HEJ; Church DN; Joseph J; Traill ZC; Sullivan ME; Tuthill MH; Verrill CL; Pintus EP; Dallas NL; Rogers PB; Redgwell J; Protheroe AS
Clin Genitourin Cancer; 2018 Jun; 16(3):240-244. PubMed ID: 29336917
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
[TBL] [Abstract][Full Text] [Related]
19. Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility.
Gray PJ; Lin CC; Sineshaw H; Paly JJ; Jemal A; Efstathiou JA
Cancer; 2015 Mar; 121(5):681-7. PubMed ID: 25345675
[TBL] [Abstract][Full Text] [Related]
20. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
